News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,864 Results
Type
Article (41407)
Company Profile (265)
Press Release (687176)
Multimedia
Podcasts (90)
Webinars (20)
Section
Business (205046)
Career Advice (2029)
Deals (35614)
Drug Delivery (126)
Drug Development (81663)
Employer Resources (174)
FDA (16529)
Job Trends (14989)
News (347228)
Policy (32806)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2608)
Academic (1)
Accelerated approval (43)
Adcomms (25)
Allergies (164)
Alliances (49680)
ALS (197)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (396)
Approvals (16869)
Artificial intelligence (616)
Autoimmune disease (236)
Automation (51)
Bankruptcy (362)
Best Places to Work (11651)
BIOSECURE Act (20)
Biosimilars (208)
Biotechnology (174)
Bladder cancer (179)
Brain cancer (68)
Breast cancer (697)
Cancer (5467)
Cardiovascular disease (453)
Career advice (1719)
Career pathing (41)
CAR-T (305)
CDC (54)
Celiac Disease (2)
Cell therapy (811)
Cervical cancer (43)
Clinical research (70513)
Collaboration (1970)
Company closure (4)
Compensation (1305)
Complete response letters (75)
COVID-19 (2734)
CRISPR (100)
C-suite (1024)
Cystic fibrosis (149)
Data (7229)
Decentralized trials (3)
Denatured (26)
Depression (156)
Dermatology (70)
Diabetes (554)
Diagnostics (6871)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (303)
Drug pricing (195)
Drug shortages (31)
Duchenne muscular dystrophy (269)
Earnings (91223)
Editorial (62)
Employer branding (21)
Employer resources (153)
Events (118945)
Executive appointments (1052)
FDA (20042)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1653)
Gene editing (214)
Generative AI (55)
Gene therapy (659)
GLP-1 (1026)
Government (4728)
Grass and pollen (6)
Guidances (401)
Healthcare (18997)
HIV (76)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (277)
Immuno-oncology (86)
Indications (164)
Infectious disease (3063)
Inflammatory bowel disease (202)
Inflation Reduction Act (14)
Influenza (133)
Intellectual property (278)
Interviews (316)
IPO (16679)
IRA (50)
Job creations (3651)
Job search strategy (1431)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (561)
Leadership (35)
Legal (7963)
Liver cancer (99)
Longevity (29)
Lung cancer (731)
Lymphoma (413)
Machine learning (54)
Management (60)
Manufacturing (955)
MASH (181)
Medical device (13899)
Medtech (13981)
Mergers & acquisitions (20120)
Metabolic disorders (1433)
mRNA (179)
Multiple sclerosis (178)
NASH (17)
Neurodegenerative disease (387)
Neuropsychiatric disorders (97)
Neuroscience (3178)
Neurotech (1)
NextGen: Class of 2026 (6536)
Non-profit (4538)
Now hiring (74)
Obesity (675)
Opinion (283)
Ovarian cancer (197)
Pain (237)
Pancreatic cancer (265)
Parkinson's disease (346)
Partnered (33)
Patents (562)
Patient recruitment (616)
Peanut (60)
People (59425)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21973)
Phase 2 (31046)
Phase 3 (23120)
Pipeline (7456)
Policy (306)
Postmarket research (2572)
Preclinical (9329)
Press Release (64)
Prostate cancer (281)
Psychedelics (51)
Radiopharmaceuticals (311)
Rare diseases (1004)
Real estate (5974)
Recruiting (70)
Regulatory (25134)
Reports (54)
Research institute (2420)
Resumes & cover letters (353)
Rett syndrome (33)
RNA editing (18)
RSV (88)
Schizophrenia (167)
Series A (272)
Series B (205)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3645)
State (2)
Stomach cancer (19)
Supply chain (126)
Tariffs (87)
The Weekly (62)
Vaccines (1067)
Venture capital (100)
Weight loss (432)
Women's health (114)
Worklife (20)
Date
Today (126)
Last 7 days (613)
Last 30 days (2585)
Last 365 days (30182)
2026 (9115)
2025 (30264)
2024 (35281)
2023 (40147)
2022 (51265)
2021 (55793)
2020 (54184)
2019 (46645)
2018 (35117)
2017 (32200)
2016 (31564)
2015 (37642)
2014 (31409)
2013 (26431)
2012 (28614)
2011 (29319)
2010 (27370)
Location
Africa (739)
Alabama (91)
Alaska (7)
Arizona (335)
Arkansas (14)
Asia (39671)
Australia (6514)
California (12483)
Canada (3583)
China (1262)
Colorado (536)
Connecticut (542)
Delaware (376)
Europe (86047)
Florida (1883)
Georgia (403)
Hawaii (3)
Idaho (62)
Illinois (992)
India (84)
Indiana (576)
Iowa (22)
Japan (504)
Kansas (129)
Kentucky (46)
Louisiana (38)
Maine (75)
Maryland (1504)
Massachusetts (8931)
Michigan (349)
Minnesota (686)
Mississippi (6)
Missouri (142)
Montana (33)
Nebraska (29)
Nevada (137)
New Hampshire (85)
New Jersey (3326)
New Mexico (28)
New York (3296)
North Carolina (1591)
North Dakota (8)
Northern California (6187)
Ohio (373)
Oklahoma (23)
Oregon (41)
Pennsylvania (2527)
Puerto Rico (28)
Rhode Island (50)
South America (1115)
South Carolina (82)
South Dakota (2)
Southern California (4918)
Tennessee (201)
Texas (1971)
United States (44259)
Utah (376)
Vermont (1)
Virginia (296)
Washington D.C. (80)
Washington State (1002)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
728,864 Results for "h3 biomedicine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
February 27, 2026
·
3 min read
Press Releases
Fortitude Biomedicines Announces Lead Program Targeting Disease-Driven T-cell Signaling Pathways for the Treatment of Axial Spondyloarthritis
April 7, 2026
·
3 min read
Press Releases
TRIANA Biomedicines Announces Oral Presentation of TRI-611 and Additional Poster Presentations at the American Association for Cancer Research Annual Meeting 2026
April 15, 2026
·
4 min read
Press Releases
TRIANA Biomedicines’ TRI-611 Granted U.S. FDA Fast Track Designation for Treatment of ALK Positive Non-small Cell Lung Cancer
March 25, 2026
·
3 min read
Press Releases
WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody
January 29, 2026
·
4 min read
Press Releases
TRIANA Biomedicines Announces First Patient Dosed in a Phase 1/2 Trial Evaluating TRI-611 for the Treatment of ALK Positive Non-small Cell Lung Cancer
March 19, 2026
·
3 min read
Press Releases
Fortitude Biomedicines Launches With $13M in Financing to Advance Novel Antibody-based Therapies for Treatment of Autoimmune Diseases and Cancer
January 27, 2026
·
4 min read
Press Releases
Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer
January 13, 2026
·
3 min read
Press Releases
Microbix Launches New Products to Support H3N2 Flu Testing
December 10, 2025
·
5 min read
Press Releases
Allele Biotech to Partner with UC San Diego on ARPA-H Project to End Liver Transplant Shortage with 3D Bioprinting
January 14, 2026
·
2 min read
1 of 72,887
Next
